Neurometrix Inc (NURO) Return on Assets ROA from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neurometrix Inc   (NASDAQ: NURO)


Neurometrix Inc 's ROA from the fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Neurometrix Inc 's ROA in the fourth quarter of 2024?
Neurometrix Inc recorded a cumulative net loss of $-8 million during 12 months ending in the fourth quarter of 2024, resulting in a negative return on assets (ROA) of -43.3%.

However, within the Healthcare sector 633 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2024 from 4102 to 4716.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Total Assets Change -45.08 % -19.25 % -16.88 % -55.56 % 13.1 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -8 -8 -8 -8 -7
Return On Assets (TTM) -43.3 % -36.25 % -35.75 % -34.48 % -22.05 %
NURO's Total Ranking # 4716 # 4102 # 4109 # 4133 # 4568
Total Assets (TTM) in million 15 17 19 21 28
Seq. Total Assets Change -10.85 % -9.2 % -8.39 % -25.94 % 31.07 %
Seq. Net Income Change - - - - -

NURO's 5 Years Annual ROA >> Back to NURO Management Effectiveness >> Compare NURO ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 154
Sector # 634
Overall # 4647

Return On Assets Statistics
High Average Low
6.88 %
-48.61 %
-128.23 %
(Mar 31 2019)   (Dec 31 2016)





Financial Statements
Neurometrix Inc 's Assets $ 15 million NURO's Balance sheet
Neurometrix Inc 's Income $ -2 million Quarterly NURO's Income Statement
NURO's Income by Division See NURO's Income by Division



Annual Return On Assets (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2020		 (Dec 31 2019)
FY 2019
Y / Y Total Assets Change -28.47 % -13.15 % -0.88 % 271.23 % -45.31 %
Total Assets in million 15 21 25 25 7
Y / Y Net Income Change - - - - -
Net Income in million -8 -7 -4 -2 -4
Annual Return On Assets -50.94 % -30.48 % -17.9 % -9.17 % -56.28 %

NURO's 5 Years Annual ROA >> Back to NURO Management Effectiveness >> Compare NURO ROA to its Competitors



More Return On Assets Ratios
NURO's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NURO's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NURO's Competitors
Subscribers only: Roa for Neurometrix Inc 's Suppliers
Subscribers only: Return On Assets for NURO's Customers

You may also want to know
NURO's Roi NURO's Inventory Turnover Ratio NURO's Growth Rates NURO's Dividend Comparisons
NURO's Profitability Ratios NURO's Asset Turnover Ratio NURO's Dividend Growth
NURO's Roe NURO's Valuation Ratios NURO's Financial Strength Ratios NURO's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2024, within Healthcare Sector ROA

Date modified: 2026-09-26T09:59:18+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.